An application of a fullerene structure in the preparation of medications for treating Parkinson's disease. The fullerene structure comprises at least one of the following active ingredient groups: a fullerene, a metallofullerene, and a composition of the fullerene and the metallofullerene; an oil-soluble fullerene, an oil-soluble metallofullerene, and a composition of the oil-soluble fullerene and the oil-soluble metallofullerene; a water-soluble fullerene, a water-soluble metallofullerene, and a composition of the water-soluble fullerene and the water-soluble metal-lofullerene; the medicinal esters of the nine elements, or the medicinal salts of the nine elements.

By sequentially performing: a step (I) of dissolving fullerene C.sub.70 in an organic solvent to prepare a fullerene solution; a step (II) of immersing a material carbon fiber in the fullerene solution; and a step (III) of extracting the carbon fiber from the fullerene solution and drying the extracted carbon fiber, a carbon fiber on which fullerene C.sub.70 adsorbs is obtained.

A method of producing fibrous carbon nanostructures uses a fluidized bed process, and comprises supplying a source gas to a reaction site in which a supported catalyst having a particulate carrier and a catalyst supported on a surface of the carrier is fluidizing, to form fibrous carbon nanostructures on the catalyst of the supported catalyst, wherein the source gas contains a double bond-containing hydrocarbon and carbon dioxide, and a content of the carbon dioxide is 0.3 vol % or more with respect to a total volume of the source gas.

A method of producing fibrous carbon nanostructures uses a fluidized bed process, and comprises supplying a source gas to a reaction site in which a supported catalyst having a particulate carrier and a catalyst supported on a surface of the carrier is fluidizing, to form fibrous carbon nanostructures on the catalyst of the supported catalyst, wherein the source gas contains a double bond-containing hydrocarbon and carbon dioxide, and a content of the carbon dioxide is 0.3 vol % or more with respect to a total volume of the source gas.

The present invention relates to a bioactive or real-time and pathogen killing material comprised of a carbon nanostructure (preferably a fullerene but including other functionalized carbon-based nanostructures) that possess potent broad-spectrum antimicrobial properties. The present invention relates to the utilization of functionalized carbon nanostructures as a bioactive antimicrobial substance that is incorporated into a material, including a textile, fabric, solution, salve, or cream. The preferred embodiment of the present invention is fullerene derivatives that are chemically functionalized on the cage with a halogen element. The present invention pertains to a material that is suitable for barrier garments, accessory garments (shoe covers, masks, facial visors, etc.), textiles (bed sheets, blankets, towels, personal clothing, gowns, surgical drapes, curtains, drapes, pads, etc.), filtration matrices (for use in hemodialysis, hemofiltration, etc.), or aerosolized solutions, sprays, liquids, salves, or creams. The present invention further relates to a production method thereof.

The present invention relates to a bioactive or real-time and pathogen killing material comprised of a carbon nanostructure (preferably a fullerene but including other functionalized carbon-based nanostructures) that possess potent broad-spectrum antimicrobial properties. The present invention relates to the utilization of functionalized carbon nanostructures as a bioactive antimicrobial substance that is incorporated into a material, including a textile, fabric, solution, salve, or cream. The preferred embodiment of the present invention is fullerene derivatives that are chemically functionalized on the cage with a halogen element. The present invention pertains to a material that is suitable for barrier garments, accessory garments (shoe covers, masks, facial visors, etc.), textiles (bed sheets, blankets, towels, personal clothing, gowns, surgical drapes, curtains, drapes, pads, etc.), filtration matrices (for use in hemodialysis, hemofiltration, etc.), or aerosolized solutions, sprays, liquids, salves, or creams. The present invention further relates to a production method thereof.

In some implementations, a metal air battery includes a metal anode, a cathode, a body, a nano-fibrous membrane (NFM), and a hygroscopic interphase layer disposed between the cathode and the NFM. The cathode may be a carbon-based textured scaffold including a plurality of macroporous pathways to distribute oxygen and water vapor supplied by ambient air throughout the cathode and into interior portions of the body. The NFM may include dry salts to produce a liquid electrolyte when exposed to water vapor delivered by the macroporous pathways of the cathode. The hygroscopic interphase layer may include a plurality of microporous pathways configured to drain excess quantities of the water vapor from the cathode and hydrate the dry salts with the water vapor.

A nanoparticle or agglomerate which contains connected multi-walled spherical fullerenes coated in layers of graphite. In different embodiments, the nanoparticles and agglomerates have different combinations of: a high mass fraction compared to other carbon allotropes present, a low concentration of defects, a low concentration of elemental impurities, a high Brunauer, Emmett and Teller (BET) specific surface area, and/or a high electrical conductivity. Methods are provided to produce the nanoparticles and agglomerates at a high production rate without using catalysts.

A nanoparticle or agglomerate which contains connected multi-walled spherical fullerenes coated in layers of graphite. In different embodiments, the nanoparticles and agglomerates have different combinations of: a high mass fraction compared to other carbon allotropes present, a low concentration of defects, a low concentration of elemental impurities, a high Brunauer, Emmett and Teller (BET) specific surface area, and/or a high electrical conductivity. Methods are provided to produce the nanoparticles and agglomerates at a high production rate without using catalysts.

The invention pertains to a process for the production of crystalline carbon structure networks in a reactor 3 which contains a reaction zone 3b and a termination zone 3c, by injecting a thermodynamically stable micro-emulsion c, comprising metal catalyst nanoparticles, into the reaction zone 3b which is at a temperature of above 600 C., preferably above 700 C., more preferably above 900 C., even more preferably above 1000 C., more preferably above 1100 C., preferably up to 3000 C., more preferably up to 2500 C., most preferably up to 2000 C., to produce crystalline carbon structure networks e, transferring these networks e to the termination zone 3c, and quenching or stopping the formation of crystalline carbon structure networks in the termination zone by spraying in water d.